期刊文献+

促细胞增殖新基因TOX的功能研究

Function of a novel human gene TOX promoting cell proliferation
下载PDF
导出
摘要 利用GenBank中的数据,通过聚合酶链式反应(polymerase chain reaction,PCR)从人的cDNA文库中克隆得到功能基因TOX(thymocyte selection-associated high mobility group box),运用生物信息学分析其结构特性,并通过逆转录PCR(reverse transcription PCR,RT-PCR)分析TOX在细胞系中的表达;利用荧光显微镜观察其亚细胞定位情况;使用细胞生长曲线实验和流式细胞术分析TOX对细胞增殖及细胞周期的影响.结果表明:TOX基因定位于人8号染色体q12.1上,全长4 131bp,编码526个氨基酸,该蛋白质分子质量约为57ku,含有9个外显子和8个内含子,其编码蛋白为高迁移率蛋白家族成员,能参与基因调控等生理过程;TOX基因在白血病细胞系Jurkat和Raji中高表达,并定位于细胞核中;对细胞生长曲线绘制及细胞周期分析表明,TOX能够使细胞生长速度加快,且S期细胞比例明显上升.说明TOX参与了细胞增殖调控,有可能研究开发为药物靶标或疾病标志物. The completion of human genome project has led to the identification of thousands of novel genes,most of which remain unknown or poorly understood functions.Cell proliferation is a highly ordered operation process,and it plays an important role in the life activities.The abnormal regulation of cell proliferation often causes a variety of disease occurrence and development.So,the identification and function study of human functional genes involved in regulation of cell proliferation will provide new directions for mechanism research of cell proliferation and therapy strategy of various related diseases.By searching the human RefSeq and expressed sequence tag(EST) databases in GenBank,human function gene TOX(thymocyte selection-associated high mobility group box)(NCBI RefSeq No : NM_014729) was cloned from human multi-tissue cDNA library by using PCR(polymerase chain reaction) assay.Bioinformatics analysis was used to identify structural characteristics of TOX,and RT-PCR(reverse transcription PCR) was used to detect its expression in cell lines.Fluorescence microscopy was used to analyze subcellular localization of TOX,moreover,cell growth curve assay and flow cytometry experiment were used to study its effect on cell proliferation and cell cycle.The results showed that the full length human gene TOX was 4 131bp long with an in-frame stop codon upstream of the putative ATG start codon and a 3 ’-poly(A) tail,and the open reading frame(ORF) encoded 526 amino acids with a predicted molecular mass of 57ku.The human gene TOX was located on chromosome 8q12.1,and encompassed nine exons and eight introns.Bioinformatics analysis showed the human gene TOX might locate in cell nuclei.TOX-coding protein was one of high mobility group box family members,which were involved in gene regulation of physiological processes.RT-PCR analysis revealed that TOX was highly expressed in leukemia cell lines Jurkat and Raji,but was not detected in some tumor cell lines A549,H1299,H520.The analysis by constructing a TOX-GFP fusion plasmid showed that the TOX-GFP could co-localize with DAPI,a nucleusspecific fluorescent dye,suggesting that the subcellular localization of TOX was in the nucleus.There was a noted increase in cell proliferation during a 5-day period by CCK8assay,and the overexpressed TOXcould accelerate the cell growth rate,and increase the ratio of cells in S phase by flow cytometry analysis.In conclusion,human gene TOXencodes a HMG-box family protein,which can regulate gene expression such as transcription and replication through binding with DNA.TOX may regulate some gene expression in cell cycles and it is highly expressed in T and B lymphoma cell lines,suggesting that the TOX gene may regulate the development of diseases related to T and B cells.Although TOXparticular mechanism needs further research,the present results indicate that the human gene TOXis involved in the regulation of cell proliferation,and might be developed as a drug target or disease marker.
出处 《浙江大学学报(农业与生命科学版)》 CAS CSCD 北大核心 2013年第4期369-374,共6页 Journal of Zhejiang University:Agriculture and Life Sciences
基金 国家"863"计划"十二五"重点项目"药靶发现与药物分子设计技术"资助(2012AA020303) 国家自然科学基金资助项目(30900730) 国家重大新药创制专项"新药研究开发关键技术研究"资助项目(2009ZX09503-004)
关键词 TOX基因 细胞增殖 细胞周期 药物靶标 疾病标志物 TOXgene cell proliferation cell cycle drug target disease marker
  • 相关文献

参考文献18

  • 1Mabon M E, Mao X, Jiao Y, et al. Systematic identificationof gene activities promoting hypoxic death. Genetics, 2009,181(2):483-496.
  • 2Fotheringham S, Epping M T, Stimson L, et al. Genome-wide loss-of-function screen reveals an important role for theproteasome in HDAC inhibitor-induced apoplosis. CancerCell, 2009,15(1) :57-66.
  • 3刘宇明,彭智,邓唯唯,石太平,马大龙.细胞水平筛选鉴定激活核因子κB通路的新基因TMEM9B[J].生物化学与生物物理进展,2009,36(11):1423-1428. 被引量:6
  • 4武春晓,石太平,马大龙.细胞筛选平台在人类功能基因组研究中的应用[J].生物化学与生物物理进展,2005,32(11):1003-1010. 被引量:1
  • 5KasZaw M B. Wild-type p53 : tumors can’t stand it. Cell,2007,128(5):837-840.
  • 6Amoura Z, Piette J C. New therapeutic approaches toautoimmune diseases. Presse Medicate , 2006,35 (4 Pt 2):709-713.
  • 7Wang L, Gao X, Gao P, et at. Cell-based screening andvalidation of human novel genes associated with cell viability.Journal of BiomolecuLar Screening , 2006, 11(4) :369-376.
  • 8Ma X, Wang X, Gao X, et al? Identification of five humannovel genes associated with cell proliferation by cell-basedscreening from an expressed cDNA ORF library. LifeSciences , 2007, 81 (14) : 1141-1151.
  • 9Thomas J O. HMG1 and 2: architectural DNA-bindingproteins. Biochemical Society Transactions , 2001, 29(Pt 4):395-401.
  • 10O' Flaherty E, Kaye J. TOX defines a conserved subfamily ofHMG-box proteins. BMC Genomics , 2003, 4( 1) :13.

二级参考文献50

  • 1Giese K, Kaufmarm J, Pronk G J, et al. Unravelling novel intracellular pathways in cell-based assays. Drug Discovery Today, 2002, 7(3): 179-186.
  • 2Karin M, Yamamoto Y, Wang Q M. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov, 2004, 3 (1): 17-26.
  • 3Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol, 2000, 18: 621 -663.
  • 4Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol, 2002, 3(3): 221-227.
  • 5Dutta J, Fan Y, Gupta N, et al. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene, 2006, 25 (51): 6800-6816.
  • 6Bian X, McAllister-Lucas LM, Shao F, et al. NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J Biol Chem, 2001, 276(52): 48921-48929.
  • 7Hettmann T, DiDonato J, Karin M, et al. An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J Exp Med, 1999, 189(1): 145-158.
  • 8Campbell K J, Rocha S, Perkins N D. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell, 2004, 13(6): 853-865.
  • 9Bessho R, Matsubara K, Kubota M, et al. Pyrrolidine dithiocarbarnate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol, 1994, 48(10): 1883-1889.
  • 10Zingarelli B, Sheehan M, Hector R. et al. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med, 2003, 31 (1 Suppl): S105-S111.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部